GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (OTCPK:CAMRF) » Definitions » Cash Flow for Dividends

CAMRF (Camurus AB) Cash Flow for Dividends : $0.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Camurus AB Cash Flow for Dividends?

Camurus AB's cash flow for dividends for the three months ended in Dec. 2024 was $0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was $0.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.


Camurus AB Cash Flow for Dividends Historical Data

The historical data trend for Camurus AB's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camurus AB Cash Flow for Dividends Chart

Camurus AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Camurus AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Camurus AB Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Camurus AB Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Camurus AB's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.


Camurus AB Business Description

Traded in Other Exchanges
Address
Ideon Science Park, Lund, SWE, SE-223 70
Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The Camurus' clinical pipeline includes products for the treatment of dependence, pain, cancer and endocrine diseases, which are developed in-house and in collaboration with international pharmaceutical companies. The company's product pipeline includes CAM2029, CAM4072 and CAM2043.

Camurus AB Headlines

From GuruFocus

Nine Months 2020 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q3 2024 Camurus AB Earnings Call Transcript

By GuruFocus News 11-09-2024

Q1 2024 Camurus AB Earnings Call Transcript

By GuruFocus Research 05-09-2024

Q1 2022 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q1 2021 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Camurus AB Corporate Analyst Meeting Transcript

By GuruFocus Research 03-02-2024

Q1 2020 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024

Q1 2023 Camurus AB Earnings Call Transcript

By GuruFocus Research 03-02-2024